NTT DATA appoints Hani Nofal as Regional Head for Technology Solutions
NTT DATA, a global leader in digital business and technology services, recently announced Hani Nofal's appointment as Regional Head for Technology Solutions, Middle East and Africa (MEA), effective May 1, 2025.
In this strategic leadership role, Nofal will drive NTT DATA's Technology Solutions growth in the MEA region, collaborating with local teams to define and implement a growth strategy aligned with global objectives.
'We are thrilled to welcome Hani to the NTT DATA family', said Alan Turnley-Jones, CEO of NTT DATA for Middle East and Africa. 'His exceptional leadership in building high-performance teams, extensive expertise in digital, security, cloud, and networking solutions, and impressive track record in business transformation make him the ideal person to drive our Technology Solutions business forward across the region'.
With over 27 years of experience, Nofal is a seasoned technology executive and thought leader with a distinguished background in the information technology industry. Prior to joining NTT DATA, he held executive roles across both global and regional technology organizations. Most recently, he launched and led Advance Solutions Corp.'s operations across EMEA. He also held senior leadership roles at Gulf Business Machines (GBM), including General Manager – Head of Technology and Board Member of Coordinates ME, where he shaped technology strategy, drove innovation, and built strategic alliances. His leadership and vision contributed significantly to the company's growth and success. Earlier in his career, he held positions at Cisco Systems, 3Com, Digital Equipment Corporation, and Compaq.
'Our region is leading the wave of AI investment, driving the next phase of digital and economic transformation', said Nofal. 'This is the time for NTT DATA, a world leader in digital and AI infrastructure, to deliver innovation and impact. I'm proud to join the team to help clients across Middle East and Africa turn AI potential into meaningful outcomes'.
Nofal is recognized for his high-performance leadership philosophy, which emphasises a culture of respect and accountability. He has received numerous industry honours, including Technology Innovation Leader of the Year and multiple partner recognitions. He holds a Bachelor of Science in Electrical and Communication Engineering from the University of Jordan and completed Leadership and Sustainability Studies at MIT Professional Education.
Image Credit: NTT DATA
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
27-05-2025
- Zawya
World-leading cancer center, The Royal Marsden NHS Foundation Trust, using AI to push boundaries of cancer research
This partnership launches a large-scale, AI-powered service designed to accelerate cancer detection and treatment using medical imaging in the UK's National Health Service (NHS) The Royal Marsden NHS Foundation Trust is ranked among world's top cancer research centers Marks a milestone in the application of artificial intelligence for cancer research and clinical innovation Dubai, UAE/ London, UK – The Royal Marsden NHS Foundation Trust, a world-leading specialist cancer center, has today announced a pioneering partnership with NTT DATA, a global leader in digital business and technology services, and a leading enterprise imaging artificial intelligence (AI) and machine learning operations (MLOps) platform. Together, they have designed and built an advanced AI-powered radiology analysis service for the development and evaluation of AI in medical imaging, designed to transform cancer research and, ultimately, improve patient outcomes. AI's potential to enhance the speed and accuracy of identifying imaging biomarkers has long been recognized. Funded by a three-year grant from the UK's National Institute for Health and Care Research (NIHR), the service will be used for research at The Royal Marsden and the Institute of Cancer Research (ICR), including projects in collaboration with other research teams. This research initiative will focus on developing and evaluating AI algorithms to improve the accuracy of cancer evaluation, including sarcoma, lung, breast, brain and prostate cancers. This will lead to faster response times, more accurate diagnoses and better-targeted treatments. The service runs on a MLOps clinical imaging platform, built and operated by NTT DATA. To enable this, NTT DATA developed a bespoke AI computing solution leveraging high-performance Dell servers and utilizing the latest GPU processing capacity orchestrated by the platform, which helps test and manage AI algorithms and includes a large collection of radiology AI models. NTT DATA is also providing specialist imaging AI consulting services, helping researchers at The Royal Marsden test and evaluate emerging AI tools in real clinical settings, while extracting maximum insight and value from both in-house and commercial algorithms. 'AI has immense potential to support clinicians in diagnosing and treating cancer earlier and more precisely,' said Professor Dow-Mu Koh, Professor in Functional Cancer Imaging and Consultant Radiologist in Functional Imaging at The Royal Marsden. 'By working with NTT DATA and we've created a scalable research environment that allows us to explore the full potential of AI safely and in a way that could one day transform cancer diagnosis and treatment across the NHS.' Minister of State for Health, Karin Smyth, said: 'Our 10 Year Health Plan will modernize the NHS, replacing outdated systems with cutting-edge digital solutions. While this trial is in its early stages, it represents exactly the kind of collaboration between the NHS, industry and academia that will help build a health service fit for the future. Early detection saves lives, and innovations like AI will transform how cancer is diagnosed and treated – helping patients receive faster and more effective care.' Professor Mike Lewis, NIHR Scientific Director for Innovation, said: "Cancer is one of the biggest killers in the UK. That must change. This three-year grant will help researchers push the boundaries of AI-driven technology for cancer detection and diagnosis. "This AI-powered service represents the cutting edge of cancer research and it is going to transform treatment, better support NHS staff and ultimately change patients' lives. It is another great example of how NIHR-funded and supported research will ensure the best care is there when patients need it.' Tom Winstanley, Chief Technology Officer at NTT DATA UK & Ireland, commented: 'This service is a great example of responsible innovation in practice, showing the ethical, secure use of AI in healthcare. We are very proud to support The Royal Marsden in pushing the boundaries of cancer research.' Once the service is live, research teams at The Royal Marsden will be able to evaluate a range of AI models across several cancer types. These studies will generate critical insights into how AI can support clinical decision-making and shape future approaches to diagnosis and treatment. Through centralized interface and built-in monitoring tools, the research teams will also be able to track model performance over time, enabling faster feedback loops between development and deployment – a crucial step towards clinical translation. NTT DATA will continue to work closely with The Royal Marsden to support this next phase of research which will ultimately improve cancer care and patient outcomes. About NTT DATA NTT DATA is a $30+ billion trusted global innovator of business and technology services. We serve 75% of the Fortune Global 100 and are committed to helping clients innovate, optimize and transform for long-term success. As a Global Top Employer, we have experts in more than 50 countries and a robust partner ecosystem of established and start-up companies. Our services include business and technology consulting, data and artificial intelligence, and industry solutions, as well as the development, implementation and management of applications, infrastructure and connectivity. We are also one of the world's leading providers of digital and AI infrastructure. NTT DATA is part of NTT Group, which invests over $3.6 billion each year in R&D to help organizations and society move confidently and sustainably into the digital future. Visit us at About The Royal Marsden NHS Foundation Trust The Royal Marsden opened in 1851 as the world's first hospital dedicated to cancer diagnosis, treatment, research and education. Today it operates as a specialist cancer center and the Trust was delighted to welcome Her Royal Highness, The Princess of Wales, who became Joint Patron with His Royal Highness The Prince of Wales, in January this year. Together with its principal academic partner, The Institute of Cancer Research (ICR), The Royal Marsden is designated as the UK's only National Institute for Health and Care Research (NIHR) Biomedical Research Centre (BRC) dedicated solely to cancer. The Royal Marsden and the ICR are recognized as one of the top four comprehensive cancer centers in the world for the impact of their research, influencing cancer treatment and care for all cancer patients. It is a center of excellence, pioneering the very latest in cancer treatments and technologies, as well as leading the way in innovative cancer diagnosis and education. The Royal Marsden operates from three centers, in Chelsea, Sutton and Cavendish Square in central London. It also has a Medical Day Unit in Kingston and is the founder and host of RM Partners West London Cancer Alliance, which includes St George's University Hospitals NHS Foundation Trust, Imperial Healthcare NHS Trust, and other healthcare partners across northwest and southwest London. Driven by the fundamental principle that patients, entrusting their lives to The Royal Marsden, deserve the very best, The Royal Marsden is committed to delivering excellent research‑led cancer care for patients, accelerating early diagnosis, and ensuring treatment and care is personalized for the needs of each individual.
Channel Post MEA
27-05-2025
- Channel Post MEA
GBM Enhances Cybersecurity at PRIME Health with Managed Detection and Response Service
Gulf Business Machines (GBM) has entered a strategic partnership with PRIME Health to deliver a comprehensive managed detection and response (MDR) service designed to enhance cybersecurity across the healthcare provider's ecosystem. Through this collaboration, GBM will deliver around-the-clock threat monitoring, rapid detection, and swift incident response to protect PRIME Health's digital environment. At the core of the collaboration are fully managed Security Information and Event Management (SIEM) and Security Orchestration, Automation, and Response (SOAR) platforms, empowering security teams with automated workflows, real-time insights, and a unified dashboard for enhanced visibility and faster decision-making. In addition, PRIME Health will leverage GBM's expert Digital Forensics and Incident Response (DFIR) team to rapidly investigate and contain threats, while gaining access to contextual, healthcare-specific threat intelligence. Furthermore, the partnership will help safeguard the healthcare provider's digital reputation by proactively monitoring for misuse, impersonation, and threats targeting the brand. Beyond day-to-day operations, GBM will also provide ongoing support to strengthen PRIME Health's cybersecurity posture, ensuring continuous alignment with best practices, regulatory compliance, and evolving threat landscapes. Driven by a strong commitment to technological advancement in healthcare, the UAE's digital health market is projected to reach US$ 2.65 billion by 2030. The collaboration further taps into this opportunity by proactively identifying and mitigating cyber threats targeting patient data and medical devices, thereby contributing to safeguarding the critical healthcare ecosystem in the UAE. Jaleel Rahiman, IT Director at PRIME Health, said, 'At PRIME Health, we recognize that cybersecurity is essential for ensuring operational resilience and safeguarding patient data, and preserving the trust of every individual who walks through our doors. As part of our continued pursuit of excellence, we were looking for a globally recognized provider that could deliver top-grade cybersecurity while securing our complex environment end to end so that our internal teams are free to focus on innovation and care delivery. This initiative reflects our promise of 'Personalised Care, Personally'—where every patient interaction is built on a foundation of trust and data confidentiality. With its proven reputation, strong partnerships, and local presence in the UAE, GBM is our trusted partner in supporting our security goals and compliance roadmap.' Ossama El Samadoni, General Manager of GBM Dubai, said, 'Our MDR service will enable PRIME Health to ensure uninterrupted care delivery while staying ahead of cyber threats. Our multi-layered collaboration reflects our shared commitment to building a secure and resilient healthcare environment. We are delighted to help PRIME Health demonstrate leadership in secure digital transformation, build patient trust by proactively defending sensitive health data, and strengthen their reputation as a security-conscious, future-ready healthcare provider.' PRIME Health is one of the UAE's most trusted healthcare providers, known for its commitment to medical excellence and patient-centric care. With a portfolio that includes Prime Hospital, Prime Medical Centers, Premier Diagnostic Center, Medi Prime Pharmacies, and specialized services such as Home Care and Corporate Medical Services, the company plays a vital role in the UAE's healthcare landscape. The group's leadership continues to drive innovation across clinical, operational, and digital domains.
TECHx
26-05-2025
- TECHx
Cybersecurity Solutions: GBM Partners with PRIME Health
Home » Smart Sectors » Healthcare » GBM Partners with PRIME Health on Cybersecurity Solutions Gulf Business Machines (GBM), a leading digital solutions provider, has announced a strategic partnership with PRIME Health. The collaboration aims to deliver advanced cybersecurity solutions to protect PRIME Health's digital ecosystem. According to the announcement, the partnership introduces a fully managed detection and response (MDR) service. This includes 24/7 threat monitoring, fast detection, and immediate incident response. At the core of this initiative are Security Information and Event Management (SIEM) and Security Orchestration, Automation, and Response (SOAR) platforms. These tools offer real-time insights, automated workflows, and a unified dashboard. They are designed to improve visibility and speed up decision-making. GBM also revealed that PRIME Health will have access to its expert Digital Forensics and Incident Response (DFIR) team. This team will investigate and contain threats quickly. Moreover, PRIME Health will benefit from specialized, contextual threat intelligence tailored to the healthcare sector. The partnership is expected to: Safeguard PRIME Health's digital reputation Monitor and mitigate threats such as impersonation and misuse Additionally, GBM will provide ongoing support to strengthen PRIME Health's cybersecurity posture. This includes maintaining regulatory compliance and aligning with evolving cybersecurity best practices. The UAE's digital health market is projected to reach US$2.65 billion by 2030. The collaboration supports this growth by protecting patient data and medical devices from cyber threats. Jaleel Rahiman, IT Director at PRIME Health, stated that cybersecurity is vital for operational resilience and patient trust. He emphasized that GBM's expertise will allow PRIME Health's internal teams to focus on innovation and care delivery. Ossama El Samadoni, General Manager of GBM Dubai, reported that the MDR service will help PRIME Health stay ahead of threats. He added that the initiative demonstrates leadership in secure digital transformation. PRIME Health is recognized as one of the UAE's most trusted healthcare providers. Its portfolio includes Prime Hospital, Prime Medical Centers, Premier Diagnostic Center, Medi Prime Pharmacies, and services like Home Care and Corporate Medical Services. With rising cyber threats in the Middle East and North Africa, the demand for strong cybersecurity solutions continues to grow. The region's cybersecurity market is expected to reach US$4.63 billion this year. This collaboration between GBM and PRIME Health marks a major step in building a secure healthcare environment in the UAE.
